Giorgio Treglia

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


490 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ...
 
EANM/SNMMI guideline/procedure standard for [<sup>18</sup>F]FDG hybrid PET use in infection and inflammation in adults v2.0.
Abikhzer G., Treglia G., Pelletier-Galarneau M., Buscombe J., Chiti A., Dibble E.H., Glaudemans AWJM, Palestro C.J., Sathekge M., Signore A. et al. European journal of nuclear medicine and molecular imaging. Peer-reviewed.
 
Diagnostic performance of 2-[18F]FDG PET/CT in recurrent differentiated thyroid cancer and elevated antithyroglobulin antibodies: an updated systematic review and bivariate meta-analysis.
Albano D., Piccardo A., Rizzo A., Cuzzocrea M., Bottoni G., Bellini P., Bertagna F., Treglia G. Endocrine. Peer-reviewed.
 
Assessment of the therapeutic efficacy of [177Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
Almeida L.S., García Megías I., Etchebehere ECSC, Calapaquí Terán A.K., Herrmann K., Giammarile F., Treglia G., Delgado Bolton R.C. European journal of nuclear medicine and molecular imaging. Peer-reviewed.
 
Iliococcygeus fixation for the treatment of vaginal vault prolapse: a systematic review and meta-analysis.
Braga A., Amato G., Caccia G., Papadia A., Treglia G., Scancarello C., Salvatore S., Torella M., Baruch Y., Serati M. Minerva urology and nephrology. Peer-reviewed.
 
Refining the role of presurgical PET/4D-CT in a large series of patients with primary hyperparathyroidism undergoing [<sup>18</sup>F]Fluorocholine PET/CT.
Kaseb A., Benider H., Treglia G., Cusumano C., Bessac D., Trimboli P., Vix M., Piccardo A., Latgé A., Imperiale A. European journal of clinical investigation. Peer-reviewed.
 
Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.
Pedrani M., Salfi G., Merler S., Testi I., Cani M., Turco F., Trevisi E., Tortola L., Treglia G., Di Tanna G.L. et al. European urology oncology. Peer-reviewed.
 
"Rosary Sign" at Somatostatin Receptor PET in a Case of Recurrent Meningioma.
Iacovitti C.M., Bosetti D.G., Muoio B., Cuzzocrea M., Paone G., Treglia G., 2024/11/20. Diagnostics, 14 (22). Peer-reviewed.
 
Evidence-Based Data on the Diagnostic Role and Clinical Usefulness of [<sup>18</sup>F]FDG PET/CT in Endocarditis and Cardiac Device Infections.
Caporali E., Paone G., Moschovitis G., De Perna M.L., Lo Priore E., Bernasconi E., Pedrazzini G., Treglia G., 2024/11. Echocardiography, 41 (11) pp. e15934. Peer-reviewed.
 
Diagnostic Performance of Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography in Patients Diagnosed with Different Types of Breast Cancer: A Systematic Review.
Rizzo A., Albano D., Marchiò C., Dondi F., Racca M., Bertagna F., Fiz F., Piccardo A., Treglia G., 2024/10/24. International journal of molecular sciences, 25 (21). Peer-reviewed.
 
[18F]Fluorocholine PET/CT as First-Line vs. Second-Line Imaging Method to localize parathyroid adenomas in primary hyperparathyroidism: “Game, Set, and Match”.
Treglia G., Piccardo A., Paone G., Trimboli P., Imperiale A., 2024/10. European journal of nuclear medicine and molecular imaging, 51 (12) pp. 3596-3599. Peer-reviewed.
 
Further explanations about the role of thyroid scintigraphy in the era of TIRADS.
Trimboli P., Bojunga J., Deandrea M., Frasca F., Imperiale A., Leoncini A., Paone G., Pitoia F., Rotondi M., Sadeghi R. et al., 2024/10. Endocrine, 86 (1) pp. 124-126. Peer-reviewed.
The Homunculus of unspecific bone uptakes associated with PSMA-targeted tracers: a systematic review-based definition.
Rizzo A., Morbelli S., Albano D., Fornarini G., Cioffi M., Laudicella R., Dondi F., Grimaldi S., Bertagna F., Racca M. et al., 2024/10. European journal of nuclear medicine and molecular imaging, 51 (12) pp. 3753-3764. Peer-reviewed.
 
What Is the Role of [<sup>18</sup>F]FDG PET/CT in the "Recommendations for Updating Fever and Inflammation of Unknown Origin From a Modified Delphi Consensus Panel" by Wright et al?
Albano D., Treglia G., 2024/10. Open forum infectious diseases, 11 (10) pp. ofae536. Peer-reviewed.
 
Role of 64CuCl2 PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and 18F-FDG PET/CT.
Piccardo A., Bottoni G., Puppo C., Massollo M., Ugolini M., Shoushtari Zadeh Naseri M., Melani E., Tomasello L., Boitano M., DeCensi A. et al., 2024/09/03. Journal of nuclear medicine, 65 (9) pp. 1357-1363. Peer-reviewed.
 
NIFTP-adjusted risk estimation of Bethesda thyroid cytology categories should consider the indication for FNA according to TIRADS.
Leoncini A., Camponovo C., Gamarra E., Piticchio T., Ruinelli L., Rotondi M., Cantisani V., Treglia G., Trimboli P., 2024/09. Endocrine, 85 (3) pp. 1261-1267. Peer-reviewed.
 
Reappraising the role of thyroid scintigraphy in the era of TIRADS: A clinically-oriented viewpoint.
Trimboli P., Bojunga J., Deandrea M., Frasca F., Imperiale A., Leoncini A., Paone G., Pitoia F., Rotondi M., Sadeghi R. et al., 2024/09. Endocrine, 85 (3) pp. 1035-1040. Peer-reviewed.
 
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.
Turco F., Gillessen S., Treglia G., Fizazi K., Smith M.R., Tombal B., Cathomas R., Buttigliero C., Di Maio M., Tucci M. et al., 2024/09. Prostate cancer and prostatic diseases, 27 (3) pp. 385-392. Peer-reviewed.
 
Imaging through PSMA-targeted PET in patients diagnosed with radioiodine-refractory thyroid cancer, a flash in the pan or a game changer?
Rizzo A., Piccardo A., Treglia G., 2024/08. Endocrine, 85 (2) pp. 601-603. Peer-reviewed.
Risk of TIRADS-based inappropriate FNAC in autonomous thyroid nodules is clinically negligible.
Leoncini A., Camponovo C., Paone G., Gamarra E., Treglia G., Trimboli P., 2024/08/01. European thyroid journal, 13 (4). Peer-reviewed.
 
Somatostatin receptor imaging of thyroid tissue and differentiated thyroid cancer using gallium-68-labeled radiotracers-a review of clinical studies.
Pishdad R., Treglia G., Mehta A., Santhanam P., 2024/08. Endocrine, 85 (2) pp. 566-575. Peer-reviewed.
 
Prognostic Role of Pre- and Post-Treatment [18F]FDG PET/CT in Squamous Cell Carcinoma of the Oropharynx in Patients Treated with Chemotherapy and Radiotherapy.
Dondi F., Gazzilli M., Albano D., Rizzo A., Treglia G., Pisani A.R., Palumbo C., Rubini D., Racca M., Rubini G. et al., 2024/07/29. Medical sciences, 12 (3). Peer-reviewed.
 
Performance of [<sup>18</sup>F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis.
Treglia G., Albano D., Rizzo A., Bellasi A., Glaudemans AWJM, Gheysens O., 2024/07/25. Diagnostics, 14 (15). Peer-reviewed.
 
Dual-Tracer Positron Emission Tomography/Computed Tomography with [<sup>18</sup>F]FDG and [<sup>18</sup>F]fluorocholine in a Patient with Metastatic Parathyroid Carcinoma.
Iacovitti C.M., Cuzzocrea M., Gianola L., Paone G., Treglia G., 2024/07/17. Diagnostics, 14 (14). Peer-reviewed.
 
The Potential Role of PSMA-Targeted PET in Salivary Gland Malignancies: An Updated Systematic Review.
Rizzo A., Albano D., Elisei F., Racca M., Dondi F., Annunziata S., Cuzzocrea M., Bertagna F., Treglia G., 2024/07/14. Diagnostics, 14 (14). Peer-reviewed.
 
2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome.
Albano D., Calabrò A., Talin A., Dondi F., Pagani C., Tucci A., Treglia G., Bertagna F., 2024/07. Annals of hematology, 103 (7) pp. 2419-2427. Peer-reviewed.
 
EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin.
Hess S., Noriega-Álvarez E., Leccisotti L., Treglia G., Albano D., Roivainen A., Glaudemans AWJM, Gheysens O., 2024/07. European journal of nuclear medicine and molecular imaging, 51 (9) pp. 2597-2613. Peer-reviewed.
Natural History of Myocardial α<sub>v</sub>β<sub>3</sub> Integrin Expression After Acute Myocardial Infarction: Correlation with Changes in Myocardial Blood Flow.
Dietz M., Kamani C.H., Bousige C., Dunet V., Delage J., Rubimbura V., Nicod Lalonde M., Treglia G., Schaefer N., Nammas W. et al., 2024/07/01. Journal of nuclear medicine, 65 (7) pp. 1107-1112. Peer-reviewed.
Increased [<sup>68</sup>Ga]Ga-SST uptake in the uncinate pancreatic process in new digital PET/CT machine and potential association with clinical and histologic factors in NET patients.
Firsova M., Treglia G., Sempoux C., Dromain C., Prior J.O., Schaefer N., Boughdad S., 2024/06/24. EJNMMI reports, 8 (1) p. 18. Peer-reviewed.
 
The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review.
Albano D., Rizzo A., Slart RHJA, Hess S., Noriega-Álvarez E., Wakfie-Corieh C.G., Leccisotti L., Glaudemans AWJM, Gheysens O., Treglia G., 2024/05/31. Pharmaceuticals, 17 (6). Peer-reviewed.
 
The Clinical Role of CXCR4-Targeted PET on Lymphoproliferative Disorders: A Systematic Review.
Zamanian M., Albano D., Treglia G., Rizzo A., Abedi I., 2024/05/16. Journal of clinical medicine, 13 (10). Peer-reviewed.
The Diagnostic Performance of 2-[18F]FDG PET/CT in Identifying Richter Transformation in Chronic Lymphocytic Leukemia: An Updated Systematic Review and Bivariate Meta-Analysis.
Albano D., Rizzo A., Racca M., Muoio B., Bertagna F., Treglia G., 2024/05/05. Cancers, 16 (9). Peer-reviewed.
 
Expanding the clinical indications of [18F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded.
Treglia G., Rizzo A., Piccardo A., 2024/04. European journal of nuclear medicine and molecular imaging, 51 (5) pp. 1345-1348. Peer-reviewed.
The Role of PSMA PET Imaging in the Classification of the Risk of Prostate Cancer Patients: A Systematic Review on the Insights to Guide an Active Surveillance Approach.
Dondi F., Antonelli A., Suardi N., Treglia G., Bertagna F., 2024/03/11. Cancers, 16 (6). Peer-reviewed.
Potential Diagnostic Role of Hepcidin in Anemic Patients Affected by Inflammatory Bowel Disease: A Systematic Review.
Ferrari F., Carini M., Zanella I., Treglia G., Luglio G., Bresciani R., Biasiotto G., 2024/02/09. Diagnostics, 14 (4). Peer-reviewed.
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review.
Dondi F., Gatta R., Treglia G., Piccardo A., Albano D., Camoni L., Gatta E., Cavadini M., Cappelli C., Bertagna F., 2024/02. Reviews in endocrine & metabolic disorders, 25 (1) pp. 175-186. Peer-reviewed.
 
Does it work in childhood and adolescence? The predictive role of postoperative/preablative stimulated thyroglobulin levels in paediatric thyroid cancer. A systematic review of the literature.
Piccardo A., Fiz F., Bottoni G., Foppiani L., Albano D., Bertagna F., Catrambone U., Mariani F., Sambucco B., Massollo M. et al., 2024/02. Reviews in endocrine & metabolic disorders, 25 (1) pp. 53-63. Peer-reviewed.
 
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities.
Imperiale A., Berti V., Burgy M., Cazzato R.L., Piccardo A., Treglia G., 2024/02. Reviews in endocrine & metabolic disorders, 25 (1) pp. 187-202. Peer-reviewed.
The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.
Piccardo A., Treglia G., Fiz F., Bar-Sever Z., Bottoni G., Biassoni L., Borgwardt L., de Keizer B., Jehanno N., Lopci E. et al., 2024/02. European journal of nuclear medicine and molecular imaging, 51 (3) pp. 756-767. Peer-reviewed.
 
Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals?
Gheysens O., Treglia G., Masri A., Hyafil F., Dorbala S., 2024/02. European journal of nuclear medicine and molecular imaging, 51 (3) pp. 691-694. Peer-reviewed.
Antiandrogens as Therapies for COVID-19: A Systematic Review.
Cani M., Epistolio S., Dazio G., Modesti M., Salfi G., Pedrani M., Isella L., Gillessen S., Vogl U.M., Tortola L. et al., 2024/01/10. Cancers, 16 (2). Peer-reviewed.
 
Detection of cardiac neuroendocrine tumour metastases by somatostatin receptor PET/CT: a systematic review and meta-analysis.
Campanale D., Imperiale A., Albano D., Rizzo A., Piccardo A., Treglia G., 2024. Frontiers in medicine, 11 p. 1491181. Peer-reviewed.
Diagnostic yield of FAP-guided positron emission tomography in thyroid cancer: a systematic review.
Rizzo A., Albano D., Dondi F., Cioffi M., Muoio B., Annunziata S., Racca M., Bertagna F., Piccardo A., Treglia G., 2024. Frontiers in medicine, 11 p. 1381863. Peer-reviewed.
Editorial: A year in review: discussions in nuclear medicine.
Albano D., Treglia G., 2024. Frontiers in medicine, 11 p. 1370082. Peer-reviewed.
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
Oprea-Lager D.E., MacLennan S., Bjartell A., Briganti A., Burger I.A., de Jong I., De Santis M., Eberlein U., Emmett L., Fizazi K. et al., 2024/01. European urology, 85 (1) pp. 49-60. Peer-reviewed.
Sentinel Node Mapping in Ovarian Tumors: A Study Using Lymphoscintigraphy and SPECT/CT.
Ataei Nakhaei S., Sadeghi R., Mostafavi S.M., Treglia G., Hassanzadeh M., Esmaeilpour M., Taheri N.S., Farazestanian M., 2024. Contrast media & molecular imaging, 2024 p. 5453692. Peer-reviewed.
Diagnostic Accuracy of PET with Different Radiotracers versus Bone Scintigraphy for Detecting Bone Metastases of Breast Cancer: A Systematic Review and a Meta-Analysis.
Zamanian M., Treglia G., Abedi I., 2023/12/08. Journal of imaging, 9 (12) p. 274. Peer-reviewed.
Diagnostic Accuracy of PET with <sup>18</sup>F-Fluciclovine ([<sup>18</sup>F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis.
Castello A., Albano D., Muoio B., Castellani M., Panareo S., Rizzo A., Treglia G., Urso L., 2023/12/06. Diagnostics, 13 (24) p. 3610. Peer-reviewed.
Diagnostic Accuracy of [68Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis.
Rizzo A., Miceli A., Racca M., Bauckneht M., Morbelli S., Albano D., Dondi F., Bertagna F., Galizia D., Muoio B. et al., 2023/11/30. Pharmaceuticals, 16 (12) p. 1664. Peer-reviewed.
 
Metabolic Imaging for Radiation Therapy Treatment Planning: The Role of Hybrid PET/MR Imaging.
Deantonio L., Castronovo F., Paone G., Treglia G., Zilli T., 2023/11. Magnetic resonance imaging clinics of North America, 31 (4) pp. 637-654. Peer-reviewed.
 
Role of splenic and bone marrow uptake at <sup>18</sup> F-FDG PET/CT for the assessment of large vessels vasculitis and the influence of glucocorticoids therapy on their values.
Dondi F., Albano D., Ferrarini G., Camoni L., Bellini P., Treglia G., Bertagna F., 2023/10. Journal of medical imaging and radiation oncology, 67 (7) pp. 717-725. Peer-reviewed.
Neuro-Oncology and Positron Emission Tomography: "Just Can't Get Enough".
Muoio B., Espeli V., Treglia G., 2023/09/27. Cancers, 15 (19) p. 4739. Peer-reviewed.
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review.
Dondi F., Antonelli A., Suardi N., Guerini A.E., Albano D., Lucchini S., Camoni L., Treglia G., Bertagna F., 2023/09/03. Cancers, 15 (17) p. 4404. Peer-reviewed.
Prevalence of Incidental Findings Suspicious for Transthyretin Cardiac Amyloidosis among Patients Undergoing Bone Scintigraphy: A Systematic Review and a Meta-Analysis.
Treglia G., Martinello C., Dondi F., Albano D., Bertagna F., Rizzo A., Delgado Bolton R.C., Tersalvi G., Muoio B., Riegger M. et al., 2023/09/01. Journal of clinical medicine, 12 (17) p. 5698. Peer-reviewed.
Two Birds with One Stone: Hepatocellular Carcinoma and Small Cell Lung Cancer Imaged with [18F]Fluorocholine Positron Emission Tomography/Computed Tomography.
Cuzzocrea M., Paone G., Treglia G., 2023/08/10. Diagnostics, 13 (16) p. 2639. Peer-reviewed.
Comparison of the prognostic value of impaired stress myocardial blood flow, myocardial flow reserve, and myocardial flow capacity on low-dose Rubidium-82 SiPM PET/CT.
Dietz M., Kamani C.H., Allenbach G., Rubimbura V., Fournier S., Dunet V., Treglia G., Nicod Lalonde M., Schaefer N., Eeckhout E. et al., 2023/08. Journal of nuclear cardiology, 30 (4) pp. 1385-1395. Peer-reviewed.
Diagnostic tests for medullary thyroid carcinoma: an umbrella review.
Trimboli P., Mian C., Piccardo A., Treglia G., 2023/08. Endocrine, 81 (2) pp. 183-193. Peer-reviewed.
 
A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer.
Delgado Bolton R.C., Calapaquí Terán A.K., Gómez Román J.J., Treglia G., Giammarile F., 2023/07. European journal of nuclear medicine and molecular imaging, 50 (9) pp. 2588-2590. Peer-reviewed.
 
Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study.
Bottoni G., Fiz F., Puntoni M., Matteucci F., Monti M., DeCensi A., Nanni O., Brain E., Alberini J.L., Dib B. et al., 2023/07. European journal of nuclear medicine and molecular imaging, 50 (8) pp. 2477-2485. Peer-reviewed.
 
Neurological complications of rotavirus infection in children: A systematic review and meta-analysis.
Meyer A., Mazzara C., Lava SAG, Treglia G., Bianchetti M.G., Goeggel Simonetti B., Simonetti G.D., 2023/07. Acta paediatrica, 112 (7) pp. 1565-1573. Peer-reviewed.
Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine.
Treglia G., Rufini V., Piccardo A., Imperiale A., 2023/07. Seminars in nuclear medicine, 53 (4) pp. 481-489. Peer-reviewed.
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.
Rizzo A., Racca M., Garrou F., Fenocchio E., Pellegrino L., Albano D., Dondi F., Bertagna F., Annunziata S., Treglia G., 2023/06/14. International journal of molecular sciences, 24 (12) p. 10136. Peer-reviewed.
 
Selective sentinel lymph node biopsy as a prognostic method in cutaneous malignant melanoma: a decade of experience
Noriega-Álvarez Edel, García Vicente Ana M., Talavera Rubio María P., Treglia Giorgio, Amo-Salas Mariano, Soriano Castrejón Ángel M., Poblete García Víctor M., 2023/06/09. Clinical and Translational Imaging, 11 (4) pp. 389-403.
 
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?
Fiz F., Bottoni G., Massollo M., Trimboli P., Catrambone U., Bacigalupo L., Righi S., Treglia G., Imperiale A., Piccardo A., 2023/06. The quarterly journal of nuclear medicine and molecular imaging, 67 (2) pp. 130-137. Peer-reviewed.
FAPI PET/CT in infectious, inflammatory, and rheumatological diseases: "watch it like a hawk" or "one swallow does not make a summer"?
Treglia G., Albano D., 2023/06. European journal of nuclear medicine and molecular imaging, 50 (7) pp. 1848-1850. Peer-reviewed.
The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review.
Jreige M., Kurian G.K., Perriraz J., Potheegadoo J., Bernasconi F., Stampacchia S., Blanke O., Alessandra G., Lejay N., Chiabotti P.S. et al., 2023/06. European journal of nuclear medicine and molecular imaging, 50 (7) pp. 1988-2035. Peer-reviewed.
Mother-to-child transmission of SARS-CoV-2 infection in high-income countries: a systematic review and meta-analysis of prospective observational studies.
Morniroli D., Vizzari G., Tosi M., Treglia G., Corsello A., Marchisio P., Mosca F., Agostoni C., Giannì M.L., Milani G.P. et al., 2023/05/31. Scientific reports, 13 (1) p. 8813. Peer-reviewed.
Positron Emission Tomography in Heart Failure: From Pathophysiology to Clinical Application.
Tersalvi G., Beltrani V., Grübler M.R., Molteni A., Cristoforetti Y., Pedrazzini G., Treglia G., Biasco L., 2023/05/17. Journal of cardiovascular development and disease, 10 (5) p. 220. Peer-reviewed.
Effects of vitamin D supplementation in obese and overweight children and adolescents: A systematic review and meta-analysis.
Corsello A., Macchi M., D'Oria V., Pigazzi C., Alberti I., Treglia G., De Cosmi V., Mazzocchi A., Agostoni C., Milani G.P., 2023/05/11. Pharmacological research, 192 p. 106793. Peer-reviewed.
18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
Albano D., Treglia G., Dondi F., Calabrò A., Rizzo A., Annunziata S., Guerra L., Morbelli S., Tucci A., Bertagna F., 2023/04/26. Cancers, 15 (9) p. 2494. Peer-reviewed.
Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with Radioiodine.
Albano D., Bellini P., Dondi F., Calabrò A., Casella C., Taboni S., Lombardi D., Treglia G., Bertagna F., 2023/02/16. Cancers, 15 (4) p. 1270. Peer-reviewed.
Relevance of Volumetric Parameters Applied to [<sup>68</sup>Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT.
Urso L., Castello A., Treglia G., Panareo S., Nieri A., Rambaldi I., Caracciolo M., Ortolan N., Uccelli L., Cittanti C. et al., 2023/02/07. Diagnostics, 13 (4) p. 606. Peer-reviewed.
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review.
Rizzo A., Racca M., Dall'Armellina S., Delgado Bolton R.C., Albano D., Dondi F., Bertagna F., Annunziata S., Treglia G., 2023/02/03. Diagnostics, 13 (3) p. 564. Peer-reviewed.
Comparison of integrin αvβ3 expression with 68Ga-NODAGA-RGD PET/CT and glucose metabolism with 18F-FDG PET/CT in esophageal or gastroesophageal junction cancers.
Dietz M., Dunet V., Mantziari S., Pomoni A., Dias Correia R., Testart Dardel N., Boughdad S., Nicod Lalonde M., Treglia G., Schafer M. et al., 2023/02/01. European journal of hybrid imaging, 7 (1) p. 3. Peer-reviewed.
 
Is there more than meets the eye than sentinel node localisation during lymphoscintigraphy mapping? Potential immunologic and therapeutic implications.
Delgado Bolton R.C., Calapaquí Terán A.K., Treglia G., Giammarile F., 2023/02. European journal of nuclear medicine and molecular imaging, 50 (3) pp. 635-637. Peer-reviewed.
 
Prognostic role of baseline 18F-FDG pet/CT in stage I and stage ii non-small cell lung cancer.
Dondi F., Albano D., Bellini P., Cerudelli E., Treglia G., Bertagna F., 2023/02. Clinical imaging, 94 pp. 71-78. Peer-reviewed.
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review.
Rizzo A., Racca M., Dall'Armellina S., Rescigno P., Banna G.L., Albano D., Dondi F., Bertagna F., Annunziata S., Treglia G., 2023/01/05. Cancers, 15 (2) p. 355. Peer-reviewed.
A role of FDG PET/CT for Response Assessment in Large Vessel Disease?
Treglia G., Albano D., Dondi F., Bertagna F., Gheysens O., 2023/01. Seminars in nuclear medicine, 53 (1) pp. 78-85. Peer-reviewed.
Contrast enhanced CT on PET/CT imaging in clinical routine: an international survey.
Annunziata S., Testart N., Auf der Springe K., Cuzzocrea M., Nicod Lalonde M., Schaefer N., Prior J.O., Garibotto V., Treglia G., 2023. Frontiers in medicine, 10 p. 1290956. Peer-reviewed.
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data.
Boyd LNC, Ali M., Leeflang MMG, Treglia G., de Vries R., Le Large TYS, Besselink M.G., Giovannetti E., van Laarhoven HWM, Kazemier G., 2023/01. EClinicalMedicine, 55 p. 101747. Peer-reviewed.
Does 18F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?
Imperiale A., Bani J., Bottoni G., Latgé A., Heimburger C., Catrambone U., Vix M., Treglia G., Piccardo A., 2023. Frontiers in medicine, 10 p. 1148287. Peer-reviewed.
Editorial: Insights in nuclear medicine: 2022.
Treglia G., 2023. Frontiers in medicine, 10 p. 1259644. Peer-reviewed.
 
Editorial: Molecular imaging of cardiovascular diseases: current and emerging approaches in nuclear medicine.
Vigne J., Treglia G., 2023. Frontiers in nuclear medicine, 3 p. 1362018. Peer-reviewed.
Editorial: Nuclear medicine in rheumatological diseases' therapy and diagnosis.
Treglia G., Bailly C., 2023. Frontiers in medicine, 10 p. 1171992. Peer-reviewed.
Editorial: Radiomics and artificial intelligence in radiology and nuclear medicine.
Annunziata S., Treglia G., 2023. Frontiers in medicine, 10 p. 1216434. Peer-reviewed.
 
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours
Nanni Cristina, Kobe Carsten, Baesler Bettina, Baues Christian, Boellaard Ronald, Borchmann Peter, Buck Andreas, Buvat Irene, Chapuy Bjorn, Cheson Bruce D. et al., 2023. The Lancet. Haematology, 10 (5) pp. e367-e381.
Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [<sup>18</sup>F]FDG PET/CT: A Comparison between Two PET/CT Scanners.
Dondi F., Gatta R., Albano D., Bellini P., Camoni L., Treglia G., Bertagna F., 2022/12/29. Journal of clinical medicine, 12 (1) p. 255. Peer-reviewed.
 
[<sup>18</sup>F]FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street?
Treglia G., Piccardo A., Garibotto V., 2022/12. Clinical autonomic research, 32 (6) pp. 399-401. Peer-reviewed.
 
A systematic review of contemporary phase I trials in patients with lymphoma.
Griguolo G., Zorzi M.F., Pirosa M.C., Treglia G., Bertoni F., Kuruvilla J., Zucca E., Stathis A., 2022/12. Critical reviews in oncology/hematology, 180 p. 103860. Peer-reviewed.
 
The use of the T-tube in biliary tract reconstruction during orthotopic liver transplantation: An umbrella review.
Martinino A., Pereira JPS, Spoletini G., Treglia G., Agnes S., Giovinazzo F., 2022/12. Transplantation reviews, 36 (4) p. 100711. Peer-reviewed.
Comparison between total thyroidectomy and hemithyroidectomy in TIR3B thyroid nodules management.
Albano D., Treglia G., Dondi F., Giubbini R., Galani A., Cappelli C., Bertagna F., Casella C., 2022/11. Endocrine, 78 (2) pp. 315-320. Peer-reviewed.
 
Prognostic role of baseline <sup>18</sup> F-FDG pet/CT in squamous cell carcinoma of the paranasal sinuses.
Dondi F., Pasinetti N., Guerini A., Piazza C., Mattavelli D., Bossi P., Berruti A., Ravanelli M., Farina D., Albano D. et al., 2022/11. Head & neck, 44 (11) pp. 2395-2406. Peer-reviewed.
 
Prognostic value of texture analysis of the primary tumour in high-risk neuroblastoma: An <sup>18</sup> F-DOPA PET study.
Fiz F., Bottoni G., Bini F., Cerroni F., Marinozzi F., Conte M., Treglia G., Morana G., Sorrentino S., Garaventa A. et al., 2022/11. Pediatric blood & cancer, 69 (11) pp. e29910. Peer-reviewed.
Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
Martinino A., Aloulou M., Chatterjee S., Scarano Pereira J.P., Singhal S., Patel T., Kirchgesner T.P., Agnes S., Annunziata S., Treglia G. et al., 2022/10/28. Journal of clinical medicine, 11 (21). Peer-reviewed.
Relationship between Baseline [<sup>18</sup>F]FDG PET/CT Semiquantitative Parameters and BRCA Mutational Status and Their Prognostic Role in Patients with Invasive Ductal Breast Carcinoma.
Dondi F., Albano D., Bellini P., Camoni L., Treglia G., Bertagna F., 2022/10/27. Tomography, 8 (6) pp. 2662-2675. Peer-reviewed.
Longitudinal Body Composition Changes Detected by [<sup>18</sup>F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma.
Albano D., Dondi F., Treglia G., Tucci A., Ravanelli M., Farina D., Bertagna F., 2022/10/20. Cancers, 14 (20) p. 5147. Peer-reviewed.
Bone Scintigraphy versus PSMA-Targeted PET/CT or PET/MRI in Prostate Cancer: Lessons Learned from Recent Systematic Reviews and Meta-Analyses.
Dondi F., Albano D., Bertagna F., Treglia G., 2022/09/15. Cancers, 14 (18) p. 4470. Peer-reviewed.
Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
Dondi F., Albano D., Treglia G., Bertagna F., 2022/09/13. Journal of clinical medicine, 11 (18) p. 5372. Peer-reviewed.
 
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review.
Muoio B., Albano D., Dondi F., Bertagna F., Annunziata S., Fiz F., Piccardo A., Sadeghi R., Treglia G., 2022/09. The quarterly journal of nuclear medicine and molecular imaging, 66 (3) pp. 229-233. Peer-reviewed.
 
Urethral bulking agents for the treatment of recurrent stress urinary incontinence: A systematic review and meta-analysis.
Braga A., Caccia G., Papadia A., Treglia G., Castronovo F., Salvatore S., Torella M., Ghezzi F., Serati M., 2022/09. Maturitas, 163 pp. 28-37. Peer-reviewed.
Could [<sup>18</sup>F]FDG PET/CT or PET/MRI Be Useful in Patients with Skull Base Osteomyelitis?
Dondi F., Albano D., Treglia G., Bertagna F., 2022/08/23. Diagnostics, 12 (9) p. 2035. Peer-reviewed.
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
Rizzo A., Dall'Armellina S., Pizzuto D.A., Perotti G., Zagaria L., Lanni V., Treglia G., Racca M., Annunziata S., 2022/08/21. Cancers, 14 (16) p. 4039. Peer-reviewed.
<sup>18</sup>F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study.
Pizzuto D.A., Triumbari EKA, Morland D., Boldrini L., Gatta R., Treglia G., Bientinesi R., De Summa M., De Risi M., Caldarella C. et al., 2022/08/14. International journal of molecular sciences, 23 (16) p. 9120. Peer-reviewed.
The Role of [<sup>68</sup>Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review.
Albano D., Dondi F., Bertagna F., Treglia G., 2022/08/05. Cancers, 14 (15) p. 3814. Peer-reviewed.
Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases.
Dondi F., Albano D., Treglia G., Bertagna F., 2022/08/03. Journal of clinical medicine, 11 (15) p. 4514. Peer-reviewed.
Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts.
Lauri C., Signore A., Glaudemans AWJM, Treglia G., Gheysens O., Slart RHJA, Iezzi R., Prakken NHJ, Debus E.S., Honig S. et al., 2022/08. European journal of nuclear medicine and molecular imaging, 49 (10) pp. 3430-3451. Peer-reviewed.
Prevalence of Brain Incidental Lesions Detected by <sup>68</sup>Ga-DOTA Peptides PET/CT.
Albano D., Treglia G., Dondi F., Bertagna F., 2022/07/10. Medicina, 58 (7) p. 916. Peer-reviewed.
Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis.
Muoio B., Albano D., Dondi F., Bertagna F., Garibotto V., Kunikowska J., Piccardo A., Annunziata S., Espeli V., Migliorini D. et al., 2022/07/08. Diagnostics, 12 (7) p. 1665. Peer-reviewed.
Diagnostic and Prognostic Role of <sup>18</sup>F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept.
Fiz F., Bottoni G., Treglia G., Trimboli P., Piccardo A., 2022/06/22. Journal of clinical medicine, 11 (13) p. 3589. Peer-reviewed.
 
Nuclear medicine practice in the field of infection and inflammation imaging: a pragmatical survey.
Annunziata S., Treglia G., Jamar F., Lauri C., Palestro C.J., Gheysens O., Glaudemans AWJM, 2022/06. European journal of nuclear medicine and molecular imaging, 49 (7) pp. 2113-2119. Peer-reviewed.
 
Prognostic Role of "Radiological" Sarcopenia in Lymphoma: A Systematic Review.
Albano D., Dondi F., Ravanelli M., Tucci A., Farina D., Giubbini R., Treglia G., Bertagna F., 2022/05. Clinical lymphoma, myeloma & leukemia, 22 (5) pp. e340-e349. Peer-reviewed.
Prostate Cancer and Sleep Disorders: A Systematic Review.
Sparasci D., Napoli I., Rossi L., Pereira-Mestre R., Manconi M., Treglia G., Marandino L., Ottaviano M., Turco F., Mangan D. et al., 2022/03/31. Cancers, 14 (7) p. 1784. Peer-reviewed.
Head-to-Head Comparison between <sup>18</sup>F-FES PET/CT and <sup>18</sup>F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis.
Piccardo A., Fiz F., Treglia G., Bottoni G., Trimboli P., 2022/03/30. Journal of clinical medicine, 11 (7) p. 1919. Peer-reviewed.
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis.
Galiandro F., Agnes S., Moschetta G., Orlandi A., Clarke G., Bria E., Franceschini G., Treglia G., Giovinazzo F., 2022/03/26. Cancers, 14 (7) p. 1691. Peer-reviewed.
Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
Roustaei H., Kiamanesh Z., Askari E., Sadeghi R., Aryana K., Treglia G., 2022. Contrast media & molecular imaging, 2022 p. 3948873. Peer-reviewed.
 
Forefoot Adduction, Hindfoot Varus or Pes Cavus: Risk Factors for Fifth Metatarsal Fractures and Jones Fractures? A Systematic Review and Meta-Analysis.
Riegger M., Müller J., Giampietro A., Saporito A., Filardo G., Treglia G., Guidi M., Candrian C., 2022. The Journal of foot and ankle surgery, 61 (3) pp. 641-647. Peer-reviewed.
Healthy Organs Uptake on Baseline <sup>18</sup>F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma.
Morland D., Triumbari EKA, Maiolo E., Cuccaro A., Treglia G., Hohaus S., Annunziata S., 2022. Frontiers in medicine, 9 p. 913866. Peer-reviewed.
Nuclear Medicine During the COVID-19 Pandemic: The Show Must Go On.
Treglia G., 2022. Frontiers in medicine, 9 p. 896069. Peer-reviewed.
Overview of the RGD-Based PET Agents Use in Patients With Cardiovascular Diseases: A Systematic Review.
Dietz M., Kamani C.H., Dunet V., Fournier S., Rubimbura V., Testart Dardel N., Schaefer A., Jreige M., Boughdad S., Nicod Lalonde M. et al., 2022. Frontiers in medicine, 9 p. 887508. Peer-reviewed.
 
Sentinel lymph node mapping in breast cancer patients following neoadjuvant chemotherapy: systematic review and meta-analysis about head to head comparison of cN0 and cN + patients.
Zarifmahmoudi L., Aghaee A., Treglia G., Sadeghi R., 2022/01. Breast cancer, 29 (1) pp. 50-64. Peer-reviewed.
<sup>18</sup>F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism.
Latge A., Riehm S., Vix M., Bani J., Ignat M., Pretet V., Helali M., Treglia G., Imperiale A., 2021/12/17. Diagnostics, 11 (12) p. 2384. Peer-reviewed.
Breast Carcinomatous Lymphangitis as an Unusual Presentation of Ovarian Cancer.
Muoio B., Treglia G., Migliora P., Del Grande M., 2021/11/14. Diagnostics, 11 (11) p. 2106. Peer-reviewed.
 
Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis.
van der Geest KSM, Treglia G., Glaudemans AWJM, Brouwer E., Sandovici M., Jamar F., Gheysens O., Slart RHJA, 2021/11. European journal of nuclear medicine and molecular imaging, 48 (12) pp. 3886-3902. Peer-reviewed.
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [<sup>18</sup>F]F-FDG in Oncology: A Systematic Review.
Treglia G., Muoio B., Roustaei H., Kiamanesh Z., Aryana K., Sadeghi R., 2021/10/17. International journal of molecular sciences, 22 (20) p. 11192. Peer-reviewed.
PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses.
Treglia G., Sadeghi R., Giovinazzo F., Galiandro F., Annunziata S., Muoio B., Kroiss A.S., 2021/10/15. Cancers, 13 (20) p. 5172. Peer-reviewed.
Management of transthyretin amyloidosis.
Condoluci A., Théaudin M., Schwotzer R., Pazhenkottil A.P., Arosio P., Averaimo M., Bacher U., Bode P., Cavalli A., Dirnhofer S. et al., 2021/10/11. Swiss medical weekly, 151 pp. w30053. Peer-reviewed.
 
Diagnostic performance and image interpretation of <sup>18</sup>F-FDG PET/CT in aortic graft infection: Two sides of the same coin.
Treglia G., Slart RHJA, Glaudemans AWJM, 2021/10. Journal of nuclear cardiology, 28 (5) pp. 2229-2232. Peer-reviewed.
Two Birds with One Stone: Skull Base Meningioma and Jugulotympanic Paragangliomas with Somatostatin Receptor Positron Emission Tomography.
Treglia G., Raditchkova M., Giovanella L., Stelmes J.J., Bosetti D.G., Martucci F., 2021/09/13. Diagnostics, 11 (9) p. 1669. Peer-reviewed.
EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases.
Aarntzen EHJG, Noriega-Álvarez E., Artiko V., Dias A.H., Gheysens O., Glaudemans AWJM, Lauri C., Treglia G., van den Wyngaert T., van Leeuwen FWB et al., 2021/09/06. EJNMMI research, 11 (1) p. 85. Peer-reviewed.
The dilemma of 18F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysis.
Scappaticcio L., Piccardo A., Treglia G., Poller D.N., Trimboli P., 2021/09. Endocrine, 73 (3) pp. 540-549. Peer-reviewed.
The "Undetermined Significance" of 18F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).
Treglia G., Bertagna F., Albano D., 2021/08/23. Medicina, 57 (8) p. 856. Peer-reviewed.
Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[18F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis.
Treglia G., Cuzzocrea M., Giovanella L., Elzi L., Muoio B., 2021/08/03. Pharmaceuticals, 14 (8) p. 762. Peer-reviewed.
 
Prevalence of physiological uptake in the pancreas on somatostatin receptor-based PET/CT: a systematic review and a meta-analysis
Boughdad Sarah, Meyer Marie, Prior John O., Fernandes Victor, Allenbach Gilles, Kamani Christel, Jreige Mario, Albano Domenico, Bertagna Francesco, Nicod-Lalonde Marie et al., 2021/08. Clinical and Translational Imaging, 9 (4) pp. 353-360. Peer-reviewed.
Unraveling the Wide Spectrum of Melanoma Biomarkers.
Revythis A., Shah S., Kutka M., Moschetta M., Ozturk M.A., Pappas-Gogos G., Ioannidou E., Sheriff M., Rassy E., Boussios S., 2021/07/26. Diagnostics, 11 (8). Peer-reviewed.
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers.
Amar L., Pacak K., Steichen O., Akker S.A., Aylwin SJB, Baudin E., Buffet A., Burnichon N., Clifton-Bligh R.J., Dahia PLM et al., 2021/07. Nature reviews. Endocrinology, 17 (7) pp. 435-444. Peer-reviewed.
 
Physiological distribution of <sup>18</sup>F-FDG in the spinal cord: A systematic review.
Kiamanesh Z., Banezhad F., Nasiri Z., Emami F., Treglia G., Sadeghi R., 2021/07. The journal of spinal cord medicine, 44 (4) pp. 517-524. Peer-reviewed.
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.
van der Geest KSM, Treglia G., Glaudemans AWJM, Brouwer E., Jamar F., Slart RHJA, Gheysens O., 2021/06. European journal of nuclear medicine and molecular imaging, 48 (6) pp. 1876-1889. Peer-reviewed.
 
SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists.
Giovanella L., Ruggeri R.M., Petranović Ovčariček P., Campenni A., Treglia G., Deandreis D., 2021/06. European journal of nuclear medicine and molecular imaging, 48 (6) pp. 1719-1723. Peer-reviewed.
To Enhance or Not to Enhance? The Role of Contrast Medium 18F-FDG PET/CT in Recurrent Ovarian Carcinomas
Massollo Michela, Fiz Francesco, Bottoni Gianluca, Ugolini Martina, Paparo Francesco, Puppo Cristina, Provinciali Nicoletta, Iacozzi Massimiliano, Altrinetti Vania, Cistaro Angelina et al., 2021/06/01. Medicina, 57 (6) p. 561.
 
Diagnostic Role of 18F-PSMA-1007 PET/CT in Prostate Cancer Staging: A Systematic Review.
Awenat S., Piccardo A., Carvoeiras P., Signore G., Giovanella L., Prior J.O., Treglia G., 2021/03/19. Diagnostics, 11 (3) p. 552. Peer-reviewed.
 
Change of management by using hybrid imaging with radiolabelled choline in biochemical recurrent prostate cancer: a systematic review and a meta-analysis
Ferrari Matteo, Renard Julien, Pereira Mestre Ricardo, Bosetti Davide G., Stoffel Flavio, Treglia Giorgio, 2021/02. Clinical and Translational Imaging, 9 (1) pp. 57-71.
 
Will 18F-fluorocholine PET/CT replace other methods of preoperative parathyroid imaging?
Giovanella L., Bacigalupo L., Treglia G., Piccardo A., 2021/02. Endocrine, 71 (2) pp. 285-297. Peer-reviewed.
 
Head-to-head comparison between 18F-FDG PET/low-dose CT and 18F-FDG PET/contrast-enhanced CT in relapsing ovarian carcinoma: a systematic review and meta-analysis
Massollo Michela, Treglia Giorgio, Trimboli Pierpaolo, Fiz Francesco, Ugolini Martina, Piccardo Arnoldo, 2021/01/05. Clinical and Translational Imaging.
<sup>18</sup>F-PSMA-1007 PET in Biochemical Recurrent Prostate Cancer: An Updated Meta-Analysis.
Ferrari M., Treglia G., 2021. Contrast media & molecular imaging, 2021 p. 3502389. Peer-reviewed.
PET findings after COVID-19 vaccination: "Keep Calm and Carry On".
Treglia G., Cuzzocrea M., Muoio B., Elzi L., 2021. Clinical and translational imaging, 9 (3) pp. 209-214. Peer-reviewed.
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review.
Giovanella L., Ruggeri R.M., Ovčariček P.P., Campenni A., Treglia G., Deandreis D., 2021. Clinical and translational imaging, 9 (3) pp. 233-240. Peer-reviewed.
The value of <sup>18</sup>F-FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysis.
Ten Hove D., Treglia G., Slart RHJA, Damman K., Wouthuyzen-Bakker M., Postma D.F., Gheysens O., Borra RJH, Mecozzi G., van Geel P.P. et al., 2021/01. European journal of nuclear medicine and molecular imaging, 48 (1) pp. 241-253. Peer-reviewed.
 
Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis.
Schwotzer R., Flammer A.J., Gerull S., Pabst T., Arosio P., Averaimo M., Bacher V.U., Bode P., Cavalli A., Concoluci A. et al., 2020/11/30. Swiss medical weekly, 150 pp. w20364. Peer-reviewed.
 
Role of 2-[<sup>18</sup>F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review.
Annunziata S., Delgado Bolton R.C., Kamani C.H., Prior J.O., Albano D., Bertagna F., Treglia G., 2020/11/10. Pharmaceuticals, 13 (11) pp. E377. Peer-reviewed.
 
Correlation between 18F-FDG PET/computer tomography findings and histology in thymic epithelial tumors: current evidences and clinical implications.
Lococo F., Sassorossi C., Chiappetta M., Cesario A., Treglia G., Margaritora S., 2020/11. Nuclear medicine communications, 41 (11) pp. 1221-1222. Peer-reviewed.
 
FNA indication according to ACR-TIRADS, EU-TIRADS and K-TIRADS in thyroid incidentalomas at 18F-FDG PET/CT.
Trimboli P., Knappe L., Treglia G., Ruberto T., Piccardo A., Ceriani L., Paone G., Giovanella L., 2020/11. Journal of endocrinological investigation, 43 (11) pp. 1607-1612. Peer-reviewed.
 
Radiolabelled PSMA PET/CT or PET/MRI in hepatocellular carcinoma (HCC): a systematic review
Dondi Francesco, Albano Domenico, Cerudelli Elisabetta, Gazzilli Maria, Giubbini Raffaele, Treglia Giorgio, Bertagna Francesco, 2020/10/27. Clinical and Translational Imaging.
 
Reliability of intraoperative ultrasound in detecting tumor residual after brain diffuse glioma surgery: a systematic review and meta-analysis.
Trevisi G., Barbone P., Treglia G., Mattoli M.V., Mangiola A., 2020/10. Neurosurgical review, 43 (5) pp. 1221-1233. Peer-reviewed.
Diagnostic Performance of 18F-FDG PET/CT in Native Valve Endocarditis: Systematic Review and Bivariate Meta-Analysis.
Kamani C.H., Allenbach G., Jreige M., Pavon A.G., Meyer M., Testart N., Firsova M., Fernandes Vieira V., Boughdad S., Nicod Lalonde M. et al., 2020/09/25. Diagnostics, 10 (10) p. 754. Peer-reviewed.
Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous.
Mattoli M.V., Treglia G., Calcagni M.L., Mangiola A., Anile C., Trevisi G., 2020/09/07. International journal of molecular sciences, 21 (18) pp. E6523. Peer-reviewed.
 
Detection of thyroiditis on PET/CT imaging: a systematic review.
Albano D., Treglia G., Giovanella L., Giubbini R., Bertagna F., 2020/09. Hormones, 19 (3) pp. 341-349. Peer-reviewed.
 
Indeterminate thyroid nodules. The role of <sup>18</sup>F-FDG PET/CT in the "era" of ultrasonography risk stratification systems and new thyroid cytology classifications.
Piccardo A., Puntoni M., Dezzana M., Bottoni G., Foppiani L., Marugo A., Catrambone U., Ugolini M., Sola S., Gatto M. et al., 2020/09. Endocrine, 69 (3) pp. 553-561. Peer-reviewed.
The Role of Imaging Techniques to Define a Peri-Prosthetic Hip and Knee Joint Infection: Multidisciplinary Consensus Statements.
Romanò C.L., Petrosillo N., Argento G., Sconfienza L.M., Treglia G., Alavi A., Glaudemans AWJM, Gheysens O., Maes A., Lauri C. et al., 2020/08/06. Journal of clinical medicine, 9 (8). Peer-reviewed.
Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses.
Annunziata S., Pizzuto D.A., Treglia G., 2020/08/04. Cancers, 12 (8). Peer-reviewed.
 
<sup>18</sup>F-FDG PET or PET/CT in Mantle Cell Lymphoma.
Albano D., Treglia G., Gazzilli M., Cerudelli E., Giubbini R., Bertagna F., 2020/07. Clinical lymphoma, myeloma & leukemia, 20 (7) pp. 422-430. Peer-reviewed.
 
Prevalence and clinical significance of incidental 18F-FDG uptake in the pituitary
Signore Giovanni, Meyer Marie, Albano Domenico, Bertagna Francesco, Nicod-Lalonde Marie, Schaefer Niklaus, Giovanella Luca, Prior John O., Treglia Giorgio, 2020/06/25. Clinical and Translational Imaging. Peer-reviewed.
 
Diagnostic performance of <sup>18</sup>F-FDG PET/CT in patients with spinal infection: a systematic review and a bivariate meta-analysis.
Treglia G., Pascale M., Lazzeri E., van der Bruggen W., Delgado Bolton R.C., Glaudemans AWJM, 2020/05. European journal of nuclear medicine and molecular imaging, 47 (5) pp. 1287-1301. Peer-reviewed.
 
Performance of Five Ultrasound Risk Stratification Systems in Selecting Thyroid Nodules for FNA.
Castellana M., Castellana C., Treglia G., Giorgino F., Giovanella L., Russ G., Trimboli P., 2020/05/01. The Journal of clinical endocrinology and metabolism, 105 (5) pp. UNSP dgz170. Peer-reviewed.
 
18F-FDG PET/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved-A Critical Review.
Albano D., Durmo R., Treglia G., Giubbini R., Bertagna F., 2020/03. Clinical lymphoma, myeloma & leukemia, 20 (3) pp. 137-146. Peer-reviewed.
 
18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!
Treglia G., Giovanella L., 2020/03. European journal of nuclear medicine and molecular imaging, 47 (3) pp. 527-528. Peer-reviewed.
 
<sup>18</sup>F-FDG PET/CT in patients with post-transplant lymphoproliferative disorders: so far so good.
Treglia G., Ceriani L., 2020/03. European journal of nuclear medicine and molecular imaging, 47 (3) pp. 523-524. Peer-reviewed.
Diagnostic Performance of <sup>18</sup>F-FDG PET or PET/CT for Detection of Post-Transplant Lymphoproliferative Disorder: A Systematic Review and a Bivariate Meta-Analysis.
Ballova V., Muoio B., Albano D., Bertagna F., Canziani L., Ghielmini M., Ceriani L., Treglia G., 2020/02/12. Diagnostics, 10 (2). Peer-reviewed.
 
The role of systematic review and meta-analysis in modern cytopathology.
Trimboli P., Treglia G., Giovanella L., Bongiovanni M., 2020/02. Cancer cytopathology, 128 (2) pp. 89-91. Peer-reviewed.
Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses.
Lococo F., Muoio B., Chiappetta M., Nachira D., Petracca Ciavarella L., Margaritora S., Treglia G., 2020. Contrast media & molecular imaging, 2020 p. 5282698. Peer-reviewed.
 
Evidence-Based Data About Prevalence and Risk of Malignancy of Thyroid Incidentalomas Detected by Different PET Radiopharmaceuticals.
Signore G., Albano D., Giovanella L., Bertagna F., Treglia G., 2020. Current radiopharmaceuticals, 13 (2) pp. 89-93. Peer-reviewed.
 
Evidence-Based PET for Cardiac Diseases
Kamani Christel H., Meyer Marie-Madeleine, Boughdad Sarah, Testart Nathalie, Nicod Lalonde Marie, Allenbach Gilles, Jreige Mario, Schaefer Niklaus, Treglia Giorgio, Prior John O., 2020. pp. 99-108 dans Evidence-based Positron Emission Tomography, Springer International Publishing.
Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas.
Bertagna F., Albano D., Cerudelli E., Gazzilli M., Giubbini R., Treglia G., 2020. Current radiopharmaceuticals, 13 (2) pp. 94-98. Peer-reviewed.
 
Prognostic and predictive value of nuclear imaging in endocrine oncology.
Treglia G., Goichot B., Giovanella L., Hindié E., Jha A., Pacak K., Taïeb D., Walter T., Imperiale A., 2020/01. Endocrine, 67 (1) pp. 9-19. Peer-reviewed.
 
Radiolabelled PSMA PET/CT in breast cancer. A systematic review.
Bertagna F., Albano D., Cerudelli E., Gazzilli M., Tomasini D., Bonù M., Giubbini R., Treglia G., 2020. Nuclear medicine review. Central & Eastern Europe, 23 (1) pp. 32-35. Peer-reviewed.
The role of <sup>18</sup>F-FDG PET for COVID-19 infection: myth versus reality.
Treglia G., 2020. Clinical and translational imaging, 8 (3) pp. 125-126. Peer-reviewed.
Selective ß2-Adrenoceptor Agonists and Relevant Hyperlactatemia: Systematic Review and Meta-Analysis.
Liedtke A.G., Lava SAG, Milani G.P., Agostoni C., Gilardi V., Bianchetti M.G., Treglia G., Faré P.B., 2019/12/27. Journal of clinical medicine, 9 (1). Peer-reviewed.
Detection Rate of Culprit Tumors Causing Osteomalacia Using Somatostatin Receptor PET/CT: Systematic Review and Meta-Analysis.
Meyer M., Nicod Lalonde M., Testart N., Jreige M., Kamani C., Boughdad S., Muoio B., Becce F., Schaefer N., Candrian C. et al., 2019/12/18. Diagnostics, 10 (1). Peer-reviewed.
 
Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups.
Taïeb D., Jha A., Treglia G., Pacak K., 2019/11. Endocrine-related cancer, 26 (11) pp. R627-R652. Peer-reviewed.
Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses.
Treglia G., Muoio B., Trevisi G., Mattoli M.V., Albano D., Bertagna F., Giovanella L., 2019/09/20. International journal of molecular sciences, 20 (19). Peer-reviewed.
Performance of 18F-FDG PET/CT in Selecting Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytology for Surgery. A Systematic Review and a Meta-Analysis.
Castellana M., Trimboli P., Piccardo A., Giovanella L., Treglia G., 2019/08/28. Journal of clinical medicine, 8 (9). Peer-reviewed.
 
Detection rate of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: an updated systematic review and meta-analysis
Signore Giovanni, Nicod-Lalonde Marie, Prior John O., Bertagna Francesco, Muoio Barbara, Giovanella Luca, Furlan Caterina, Treglia Giorgio, 2019/08. Clinical and Translational Imaging, 7 (4) pp. 237-253.
Diagnostic Performance of PET or PET/CT Using <sup>18</sup>F-FDG Labeled White Blood Cells in Infectious Diseases: A Systematic Review and a Bivariate Meta-Analysis.
Meyer M., Testart N., Jreige M., Kamani C., Moshebah M., Muoio B., Nicod-Lalonde M., Schaefer N., Giovanella L., Prior J.O. et al., 2019/06/15. Diagnostics, 9 (2). Peer-reviewed.
 
<sup>68</sup>Ga-PSMA PET thyroid incidentalomas.
Bertagna F., Albano D., Giovanella L., Bonacina M., Durmo R., Giubbini R., Treglia G., 2019/06. Hormones, 18 (2) pp. 145-149. Peer-reviewed.
 
Detection rate of unknown primary tumour by using somatostatin receptor PET/CT in patients with metastatic neuroendocrine tumours: a meta-analysis.
De Dosso S., Treglia G., Pascale M., Tamburello A., Santhanam P., Kroiss A.S., Pereira Mestre R., Saletti P., Giovanella L., 2019/06. Endocrine, 64 (3) pp. 456-468. Peer-reviewed.
Detection Rate of (18)F-Labeled PSMA PET/CT in Biochemical Recurrent Prostate Cancer: A Systematic Review and a Meta-Analysis.
Treglia G., Annunziata S., Pizzuto D.A., Giovanella L., Prior J.O., Ceriani L., 2019/05/23. Cancers, 11 (5). Peer-reviewed.
 
F18-choline/C11-choline PET/CT thyroid incidentalomas.
Bertagna F., Albano D., Giovanella L., Giubbini R., Treglia G., 2019/05. Endocrine, 64 (2) pp. 203-208. Peer-reviewed.
 
Additional value of integrated <sup>18</sup>F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile.
Piccardo A., Trimboli P., Rutigliani M., Puntoni M., Foppiani L., Bacigalupo L., Crescenzi A., Bottoni G., Treglia G., Paparo F. et al., 2019/03. European journal of nuclear medicine and molecular imaging, 46 (3) pp. 766-775. Peer-reviewed.
 
Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis.
Pereira Mestre R., Treglia G., Ferrari M., Pascale M., Mazzara C., Azinwi N.C., Llado' A., Stathis A., Giovanella L., Roggero E., 2019/03. European journal of clinical investigation, 49 (3) pp. e13063. Peer-reviewed.
 
Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis.
Treglia G., Piccardo A., Imperiale A., Strobel K., Kaufmann P.A., Prior J.O., Giovanella L., 2019/03. European journal of nuclear medicine and molecular imaging, 46 (3) pp. 751-765. Peer-reviewed.
 
PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art.
Piccardo A., Trimboli P., Foppiani L., Treglia G., Ferrarazzo G., Massollo M., Bottoni G., Giovanella L., 2019/03. Reviews in endocrine & metabolic disorders, 20 (1) pp. 47-64. Peer-reviewed.
Diagnostic Performance of <sup>18</sup>F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses.
Treglia G., 2019. Contrast media & molecular imaging, 2019 p. 3018349. Peer-reviewed.
Impact of 18F-FDG PET/CT in Staging Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Martucci F., Pascale M., Valli M.C., Pesce G.A., Froesch P., Giovanella L., Richetti A., Treglia G., 2019. Frontiers in medicine, 6 p. 336. Peer-reviewed.
 
Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis.
Treglia G., Pereira Mestre R., Ferrari M., Bosetti D.G., Pascale M., Oikonomou E., De Dosso S., Jermini F., Prior J.O., Roggero E. et al., 2019. American journal of nuclear medicine and molecular imaging, 9 (2) pp. 127-139. Peer-reviewed.
 
Brown Adipose Tissue (BAT) detection by <sup>18</sup>F-FDG PET and thyroid hormone level(s)-a systematic review.
Santhanam P., Ahima R.S., Mammen J.S., Giovanella L., Treglia G., 2018/11. Endocrine, 62 (2) pp. 496-500. Peer-reviewed.
 
Fine-needle aspiration in all thyroid incidentalomas at <sup>18</sup> F-FDG PET/CT: Can EU-TIRADS revise the dogma?
Trimboli P., Paone G., Treglia G., Virili C., Ruberto T., Ceriani L., Piccardo A., Giovanella L., 2018/11. Clinical endocrinology, 89 (5) pp. 642-648. Peer-reviewed.
 
Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
Treglia G., Glaudemans AWJM, Bertagna F., Hazenberg BPC, Erba P.A., Giubbini R., Ceriani L., Prior J.O., Giovanella L., Slart RHJA, 2018/10. European journal of nuclear medicine and molecular imaging, 45 (11) pp. 1945-1955. Peer-reviewed.
 
18F-FDG PET/CT for invasive fungal infection in immunocompromised patients.
Leroy-Freschini B., Treglia G., Argemi X., Bund C., Kessler R., Herbrecht R., Imperiale A., 2018/09/01. QJM, 111 (9) pp. 613-622. Peer-reviewed.
 
Role of positron emission tomography in thyroid and neuroendocrine tumors.
Treglia G., Kroiss A.S., Piccardo A., Lococo F., Santhanam P., Imperiale A., 2018/09. Minerva endocrinologica, 43 (3) pp. 341-355. Peer-reviewed.
 
Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods.
Treglia G., Trimboli P., Huellner M., Giovanella L., 2018/06. Minerva endocrinologica, 43 (2) pp. 133-143. Peer-reviewed.
 
Light in the dark: <sup>18</sup>F-FDG PET/CT in Staphylococcus aureus bacteremia of unknown origin.
Colombo J., Elzi L., Treglia G., Perren A., 2018/04. Intensive care medicine, 44 (4) pp. 488-489. Peer-reviewed.
 
Detection of brown adipose tissue by <sup>18</sup> F-FDG PET/CT in pheochromocytoma/paraganglioma: A systematic review.
Santhanam P., Treglia G., Ahima R.S., 2018/03. Journal of clinical hypertension, 20 (3) p. 615. Peer-reviewed.
 
Could <sup>68</sup>Ga-somatostatin analogues be an important alternative to <sup>18</sup>F-DOPA PET/CT in pediatrics?
Piccardo A., Treglia G., 2018/02. European journal of nuclear medicine and molecular imaging, 45 (2) pp. 247-249. Peer-reviewed.
 
Metástasis infrecuente de mesotelioma pleural detectada mediante <sup>18</sup>F-FDG PET/TC de cuerpo entero = Uncommon distant metastasis of pleural mesothelioma detected by whole-body <sup>18</sup>F-FDG PET/CT.
Rapicetta C., Taddei S., Casali M., Valli R., Lococo F., Treglia G., Paci M., 2018. Revista espanola de medicina nuclear e imagen molecular, 37 (2) pp. 125-127. Peer-reviewed.
Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis.
Sadeghi R., Harsini S., Qodsi Rad M.A., Dabbagh V.R., Treglia G., 2018. Contrast media & molecular imaging, 2018 p. 9760492. Peer-reviewed.
 
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
July M., Santhanam P., Giovanella L., Treglia G., 2018/01. Clinical physiology and functional imaging, 38 (1) pp. 4-9. Peer-reviewed.
 
Detection rate of somatostatin receptor PET in patients with recurrent medullary thyroid carcinoma: a systematic review and a meta-analysis.
Treglia G., Tamburello A., Giovanella L., 2017/10. Hormones, 16 (4) pp. 262-272. Peer-reviewed.
 
Is (18)F-FDG-PET suitable to predict clinical response to the treatment of geriatric depression? A systematic review of PET studies.
De Crescenzo F., Ciliberto M., Menghini D., Treglia G., Ebmeier K.P., Janiri L., 2017/09. Aging & mental health, 21 (9) pp. 889-894. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University